MAPT and Alzheimer disease: The processes leading to neurodegeneration in AD are associated with the synaptotoxicity and neurotoxicity of (i) Aβ plaques and oligomers, (ii) P-tau aggregates and oligomers, (iii) mitochondrial dysfunction, and (iv) impaired proteostasis and axonal transport [233].